ALK-Abelló A/S (CPH:ALK.B)
234.00
+4.80 (2.09%)
At close: Apr 28, 2026
ALK-Abelló Employees
ALK-Abelló had 2,613 employees as of December 31, 2025. The number of employees decreased by 140 or -5.09% compared to the previous year.
Employees
2,613
Change (1Y)
-140
Growth (1Y)
-5.09%
Revenue / Employee
2.42M DKK
Profits / Employee
458.09K DKK
Market Cap
51.85B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| Demant | 26,704 |
| H. Lundbeck | 5,039 |
| Zealand Pharma | 501 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,692 |
ALK-Abelló News
- 8 days ago - ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy - GlobeNewsWire
- 6 weeks ago - Annual General Meeting in ALK-Abelló A/S held on 16 March 2026 - GlobeNewsWire
- 6 weeks ago - ALK-Abelló Transcript: AGM 2026 - Transcripts
- 2 months ago - ALK-Abelló Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Invitation to the presentation of ALK's annual report 2025 on Friday, 20 February 2026 - GlobeNewsWire
- 3 months ago - ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children - GlobeNewsWire
- 5 months ago - ALK-Abelló Earnings Call Transcript: Q3 2025 - Transcripts
- 8 months ago - ALK-Abelló Earnings Call Transcript: Q2 2025 - Transcripts